Price target
49.500.000.00%
The 14 analysts offering 1 year price forecasts for IMVT have a max estimate of — and a min estimate of —.
Analyst rating
Based on 15 analysts giving stock ratings to IMVT in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
IMVT EPS for the last quarter is −0.65 USD despite the estimation of −0.59 USD. In the next quarter EPS is expected to reach −0.73 USD. Track more of Immunovant, Inc. financials and stay on top of what is up with the company.
In the next quarter Immunovant, Inc. revenue is expected to reach 0.00 USD. Check out Immunovant, Inc. revenue and earnings and make informed decisions.
According to analysts, IMVT price target is 49.50 USD with a max estimate of 58.00 USD and a min estimate of 36.00 USD. Check if this forecast comes true in a year, meanwhile watch Immunovant, Inc. stock price chart and keep track of the current situation with IMVT news and stock market news.
We've gathered opinions of 15 analysts rating IMVT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.